Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-Controlled, Randomized, Double-Blind, Parallel-Group, Dose-Finding Trial to Evaluate the Efficacy and Safety of TBS-2 Intranasal Testosterone Gel in Women With Acquired Female Orgasmic Disorder

NCT01607658 is registered in ClinicalTrials.gov with Acerus Pharmaceuticals Corporation as lead sponsor.

NCT NCT01607658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01607658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-Controlled, Randomized, Double-Blind, Parallel-Group, Dose-Finding Trial to Evaluate the Efficacy and Safety of TBS-2 Intranasal Testosterone Gel in Women With Acquired Female Orgasmic Disorder
Lead sponsor
Acerus Pharmaceuticals Corporation
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
May 31, 2014
Enrollment
253 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

female orgasmic disorder